Tarsus Pharmaceuticals
TARS
TARS
43 hedge funds and large institutions have $294M invested in Tarsus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 44 → 43 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
43
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.86M | |
| 2 | +$955K | |
| 3 | +$680K | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$225K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$202K |
Top Sellers
| 1 | -$934K | |
| 2 | -$478K | |
| 3 | -$389K | |
| 4 |
VEA
Virtus ETF Advisers
New York
|
-$129K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$106K |